AP Pharma

A.P. Pharma, Inc. (NASDAQ Global Market: APPA) is a specialty pharmaceutical company focused on the development and commercialization of innovative medical treatments utilizing its proprietary polymer-based drug delivery systems. We are focused on developing pharmaceutical products using our proprietary BiochronomerTM polymer-based drug delivery technology. Our product development philosophy is based on incorporating approved therapeutics into our proprietary bioerodible drug delivery technology to create controlled release pharmaceuticals to improve treatments for diseases or conditions. Our lead product candidate, APF530, is currently in a pivotal Phase III clinical trial for the prevention of acute and delayed onset chemotherapy-induced nausea and vomiting, or CINV. Our primary focus is to advance our proprietary Biochronomer technology, consisting of bioerodible polymers designed to release drugs over a defined period. We have completed over 100 in vivo and in vitro studies demonstrating that our Biochronomer technology is potentially applicable to a range of therapeutic areas, including pain management, prevention of nausea and vomiting, control of inflammation and treatment of ophthalmic diseases. We have also completed comprehensive animal and human toxicology studies that have established that our Biochronomer polymers are safe and well tolerated. Furthermore, our Biochronomer technology can be designed to deliver drugs over periods varying from days to several months.

Contact Details: 123 Saginaw Drive Redwood City 94063 Tel: 650-366-2626 Fax: Email: jobs@appharma.com WWW: www.appharma.com/

Recent Publications by AP Pharma:
Poly(ortho esters)--from concept to reality. The development of poly(ortho esters) dates back to the early 1970s, and...	23rd February, 2005	AP Pharma, 123 Saginaw Drive, Redwood City, California 94063, USA.	Biomacromolecules. 2004 Sep-Oct;5(5):1625-32. DOI Direct Link
Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. The fabrication, morphological characterization, and drug release kinetics...	23rd April, 2003	AP Pharma, Redwood City, CA 94063, USA.	Biomaterials. 2002 Nov;23(22):4405-12.

BioNews Results for AP Pharma:
Lexicon Pharma says its irritable bowel syndrome drug LX1031 met study goal; shares jump	Chicago Tribune:  Nov 15 2009 4:26AM Matching: ap pharma
Myriad Pharma posts smaller 1Q loss after spinoff	KSBY - TV:  Nov 14 2009 4:31PM Matching: ap pharma
AP Pharma Inc. (APPA) Corporate Event Announcement Notice - Zibb....	Zibb:  Nov 13 2009 3:15AM Matching: ap pharma
Lexicon Pharma says its irritable bowel syndrome drug LX1031 met study goal; shares jump	Canadian Business Magazine:  Nov 13 2009 2:51PM Matching: ap pharma
Myriad Pharma posts smaller 1Q loss after spinoff	Yahoo! Malaysia:  Nov 13 2009 2:03PM Matching: ap pharma
Promote your company here: BioNewsCast - Press Release Distribution	→View more AP Pharma news.

AP Pharma Patents:
US Patent No.	Title
6822000	Bioerodible poly (orthoesters) from dioxolane-based diketene acetals
6790458	Pharmaceutical compositions using semi-solid delivery vehicle
6590059	Bioerodible polyorthoesters from dioxolane-based diketene acetals
6524606	Bioerodible polyorthoesters containing amine groups

AP Pharma (APPA) Financial information Links from Barchart
APPA Quote from from Barchart.com
APPA Chart from from Barchart.com
APPA Profile from from Barchart.com
APPA Opinion from from Barchart.com
→View more AP Pharma finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 830 times since April 2007, the link to the organisation's website has been followed 140 times

Search for more companies in Redwood City

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AP Pharma